Abstract
The effect of anticholinesterase drugs on the clinical and electrophysiological features in a canine congenital myasthenic syndrome is compared with findings in acquired myasthenia gravis in dogs. Anticholinesterase treatment had no effect on muscle weakness or electrophysiological parameters in the congenital myasthenic syndrome in contrast to its effect on clinical signs and electrophysiological parameters in acquired myasthenia gravis. The lack of effect of anticholinesterase in congenital myasthenia suggests a presynaptic defect as the aetiological factor. No antibodies to acetylcholine receptors were found in the Danish dog breed Gammel Dansk Hønsehund with the myasthenic syndrome. This classifies the disease in the group of canine and human congenital myasthenic diseases.
Keywords: myasthenic syndrome, canine myasthenia gravis, neuromuscular transmission defect
Full Text
The Full Text of this article is available as a PDF (2.6 MB).
Acknowledgements
This investigation was aided by grants from the Danish Agricultural and Veterinary Research Council (13-3259) and from the Leo Research Foundation.
The Neuromatic 2000 was granted by the Simon Spies Foundation.
References
- Bellah JR, Stift ME, Russel RG. Thymona in the dog: Two case reports and review of 20 additional cases. J. Amer. vet. med. Assoc. 1983;183:306–331. [PubMed] [Google Scholar]
- Brown JC, Johns RJ. Clinical and physiological studies of the effect of guanidine on patients with myasthenia gravis. Johns Hopkins Med. J. 1969;124:1–8. [PubMed] [Google Scholar]
- Darke PGG, McCullagh KG, Geldart PH. Myasthenia gravis, thymona and myositis in a dog. Vet. Rec. 1975;97:392–394. doi: 10.1136/vr.97.20.392. [DOI] [PubMed] [Google Scholar]
- Engel AG, Lambert EH, Mulder DM, Gomez MR, Whitaker JN, Hart Z, Sahaski K. Recently recognized congenital myasthenic syndromes: (a) end-plate acetylcholine (ACh) esterase déficience (b) putative abnormality of the ACh induced ion channel (c) putative defect of ACh resynthesis or mobilization- clinical features, ultrastructure and cytochemistry. Ann. NY Acad Sci. 1981;377:614–639. doi: 10.1111/j.1749-6632.1981.tb33762.x. [DOI] [PubMed] [Google Scholar]
- Flagstad A. A new hereditary neuromuscular disease in the dog breed Gammel Dansk Hon- sehund. Genetic investigations. Hereditas. 1982;96:211–213. doi: 10.1111/j.1601-5223.1982.tb00851.x. [DOI] [PubMed] [Google Scholar]
- Flagstad A, Trojaborg W. Hereditary neuromuscular disease in the dog breed Gammel Dansk Honsehund. Electrophysiological findings and genetic aspects. Proceedings from Vooijaars- dagen, Amsterdam, 1983, 109-114.Flagstad A, Nielsen P, Trojaborg W: Pharmacokinetics and pharmacodynamics of guanidine hydrochloride in an hereditary myasthenia gravis like disorder in dogs. J. vet. Pharmacol. Therap. 1986;9:318–324. doi: 10.1111/j.1365-2885.1986.tb00047.x. [DOI] [PubMed] [Google Scholar]
- Hall GA, Howell JMCC, Lewis DG. Thymona with myasthenia gravis in a dog. J. Path. 1972;188:177–180. doi: 10.1002/path.1711080214. [DOI] [PubMed] [Google Scholar]
- Jenkins WL, Van Dyk E, McDonald CB. Myasthenia gravis in Foxterrier litter. J. South Afr. vet. Assoc. 1976;47:59–62. [PubMed] [Google Scholar]
- Johnson RP, Watson ADJ, Smith J, Cooper BJ. Myasthenia in Springer Spaniel littermates. J. Small Anim. Pract. 1975;16:641–647. doi: 10.1111/j.1748-5827.1975.tb05790.x. [DOI] [PubMed] [Google Scholar]
- Karmenskaya MA, Elmquist D, Thesleff S. Guanidine and neuromusular transmission. 1. Effect on transmitter release occurring spontaneously and in response to single nerve stimuli. Arch. Neurol. 1975;32:505–509. doi: 10.1001/archneur.1975.00490500025001. [DOI] [PubMed] [Google Scholar]
- Kelly MJ. Myasthenia gravis - A receptor disease. Comp. Cont. Ed. 1981;3:544–555. [Google Scholar]
- Lennon VA, Palmer AC, Pflugfelder CM, Indrieri RJ. Myasthenia gravis in dogs: Acetylcholine receptor deficiency with and without antireceptor autoantibodies. Genetic control of autoimmune disease. New York, Elsevier, North Holland Biomedical Press. 1978;1:295–305. [Google Scholar]
- Lennon VA, Lambert EH, Palmer AC, Cunningham JG, Christie TR. Acquired and congenital myasthenia gravis in dogs - a study of 20 cases. In: E S, editor. Myasthenia gravis - pathogenesis and treatment. Tokyo: University of Tokyo Press; 1981. pp. 41–54. [Google Scholar]
- Lorenz MD, De Lahunta A, Alstrom DH. Neostigmine-responsive weakness in the dog, similar to myasthenia gravis. J. Amer. vet. med. Assoc. 1972;161:795–802. [PubMed] [Google Scholar]
- Mayer RF, Williams IR. Incrementing responses in myasthenia gravis. Arch. Neurol. 1974;31:24–26. doi: 10.1001/archneur.1974.00490370050006. [DOI] [PubMed] [Google Scholar]
- Miller LM, Lennon VA, Lambert EH, Reed SM, Hegreberg GA, Miller JB, Ott RL. Congenital myasthenia gravis in 13 Smooth Fox Terrier. J. Amer. vet. med. Assoc. 1983;182:694–697. [PubMed] [Google Scholar]
- Miller LM, Hegreberg GA, Prieur DJ, Hamilton MJ. Inheritance of congenital myasthenia gravis in Smooth Fox Terrier dogs. J. Hered. 1984;75:163–166. doi: 10.1093/oxfordjournals.jhered.a109904. [DOI] [PubMed] [Google Scholar]
- Nielsen FC, Rodgaard A, Djurup R, Somnier F, Gammeltoft S. A triple antibody assay for quantitation of plasma IgG subclass antibodies to acetylcholine receptors in patients with myasthenia gravis. J. Immunol. Methods. 1985;83:249. doi: 10.1016/0022-1759(85)90247-9. [DOI] [PubMed] [Google Scholar]
- Otsuka M, Endo M. The effect of guanidine on neuromuscular transmission. J. Pharmacol. Exper. Therap. 1960;128:273–282. [PubMed] [Google Scholar]
- Palmer AC, Barker J. Myasthenia in the dogs. Vet. Rec. 1974;95:452–454. doi: 10.1136/vr.95.20.452. [DOI] [PubMed] [Google Scholar]
- Palmer AC, Goodyear JV. Congenital myasthenia in the Jack Russel Terrier. Vet. Rec. 1978;103:433–434. doi: 10.1136/vr.103.19.433. [DOI] [PubMed] [Google Scholar]
- Palmer AC. Myasthenia gravis. Vet. Clin. North Amer.: Small Anim. Pract. 1980;1:213–222. doi: 10.1016/S0195-5616(80)50012-4. [DOI] [PubMed] [Google Scholar]
- Pflugfelder CM, Car d G, Lutz H, Holliday TA, Hansen RJ. Acquired canine myasthenia gravis. Immunocytochemical localization of immune complexes at neuromuscular junctions. Muscle & Nerve. 1980;4:289–295. doi: 10.1002/mus.880040405. [DOI] [PubMed] [Google Scholar]
- Pojfenbarger E, Klausner JS, Caywood DD. Acquired myasthenia gravis in a dog with thymona: A case report. J. Amer. Anim. Hosp. Assoc. 1984;21:119–124. [Google Scholar]
- Rodgaard A, Nielsen FC, Djurup R, Somnier F, Gammeltoft S. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3. Clin. exp. Immunol. 1987;67:82–88. [PMC free article] [PubMed] [Google Scholar]
- Trojaborg W, Flagstad A. A hereditary neuromuscular disorder in dogs. Muscle & Nerve. 1982;5:30–38. [PubMed] [Google Scholar]
- Vincent A. Immunology of acetylcholine receptors in relation to Myasthenia gravis. Physiol. Rev. 1980;60:756–824. doi: 10.1152/physrev.1980.60.3.756. [DOI] [PubMed] [Google Scholar]
- Vincent A, Cull-Candy SG, Newsom-Davis J, Trautman A, Molenaar PE, Polak RL. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases. Muscle & Nerve. 1981;4:306–318. doi: 10.1002/mus.880040407. [DOI] [PubMed] [Google Scholar]
- Wallace ME, Palmer AC. Recessive mode of inheritance in myasthenia gravis in the Jack Russel Terrier. Vet. Rec. 1984;114:350. doi: 10.1136/vr.114.14.350. [DOI] [PubMed] [Google Scholar]
- Witt VM, Ludvig RD. Anticholinesterase - responsive weakness in the canine similar to myasthenia of man. J. Amer. Anim. Hosp. Assoc. 1978;14:138–142. [Google Scholar]
- Zacks SI, Shields DR, Steinberg SA. A myasthenic syndrome in the dog. A case report with electron microscopic observations on motor endplates and comparison with the fine structure of end plate in myasthenia gravis. Ann. Ny Acad. Sci. 1966;135:79–97. doi: 10.1111/j.1749-6632.1966.tb45465.x. [DOI] [PubMed] [Google Scholar]